Miles Sparrow

Crohn's disease management after intestinal resection: a randomised trial

Peter De Cruz, Michael A. Kamm, Amy L. Hamilton et al. · The Lancet · 2014 · 591 citations

Randomised Trial, Gastroenterology, Clinical Gastroenterology +2

A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy

Geoffrey M Forbes, Marian Sturm, Rupert W. Leong et al. · Clinical Gastroenterology and Hepatology · 2013 · 338 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Autoimmune Disease +11

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Mette Julsgaard, Lisbet Ambrosius Christensen, Peter G. Gibson et al. · Gastroenterology · 2016 · 321 citations · Full text

Inflammation, Rheumatology, Maternal Immunization +7

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

Konstantinos Papamichael, Adam S. Cheifetz, Gil Melmed et al. · Clinical Gastroenterology and Hepatology · 2019 · 319 citations · Full text

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Bruce E. Sands, Peter M. Irving, Timothy Hoops et al. · The Lancet · 2022 · 277 citations

Immunology, Clinical Trials, Gastroenterology +7